Drugs / PRP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02211521 | Aug 2014 → Oct 2015 | osteoarthritis, knee | Samsung Medical Center | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02211521 ↗ |
| Modality | Other / unclassified | “Platelet Rich Plasma (PRP) is a simple, low- cost and minimally- invasive method that allows one to obtain a natural concentrate of autologous GFs from the blood” NCT02211521 ↗ |
| Route | Other | “intra-articular injections of PRP” NCT02211521 ↗ |